Recombinant Human Granzyme B Protein (His tag)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human Granzyme B Protein (His tag) is a Human Full Length protein, in the 19 to 247 aa range, expressed in HEK 293 cells, with >95%, <0.005 EU/µg endotoxin level, suitable for HPLC, Mass Spec, SDS-PAGE, FuncS.
View Alternative Names
CGL1, CSPB, CTLA1, GRB, GZMB, Granzyme B, C11, CTLA-1, Cathepsin G-like 1, Cytotoxic T-lymphocyte proteinase 2, Fragmentin-2, Granzyme-2, Human lymphocyte protein, SECT, T-cell serine protease 1-3E, CTSGL1, Lymphocyte protease, HLP
- Mass Spec
Supplier Data
Mass Spectrometry - Recombinant Human Granzyme B Protein (His tag) (AB307481)
Mass determination by ESI-TOF. Predicted MW is 27234.24 Da (+/-10 Da by ESI-TOF). Observed MW is 27236.73 Da.
- Biological Activity
Lab
Biological Activity - Recombinant Human Granzyme B Protein (His tag) (AB307481)
The activity of ab307481 was determined using 50 µM substrate Ac-IEPD-AFC in a buffer containing 50 mM HEPES, 10 mM CaCl2, pH 7.5 at 37 °C.
- HPLC
Supplier Data
HPLC - Recombinant Human Granzyme B Protein (His tag) (AB307481)
HPLC analysis of ab307481
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human Granzyme B Protein (His tag) (AB307481)
SDS-PAGE analysis of ab307481
- Other
Lab
Other - Recombinant Human Granzyme B Protein (His tag) (AB307481)
ab307481 in 50 mM HEPES, 10 mM CaCl2, pH 7.5 was incubate at 37 °C for 30 minutes and assayed for residual activity.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Granzyme B participates prominently in the immune response by activating caspases particularly caspase-3 which promotes the breakdown of cellular components necessary for apoptosis. Granzyme B does not function in isolation but acts in concert with other immune system factors such as perforin to effectively induce cell death. Perforin creates pores in the target cell membrane allowing granzyme B to enter and instigate the apoptosis sequence. The enzyme also contributes to the processing of cytokines which enhances the immune response further.
Pathways
Studies have determined that granzyme B is critical in the apoptosis pathway particularly in the granule exocytosis pathway. It closely interacts with proteins such as perforin and other granzymes to mediate apoptosis in target cells. Granzyme B also plays a role in the inflammatory response and can influence pathways associated with cytotoxic T cell signaling. Its pathway interactions ensure effective elimination of damaged or infected cells maintaining tissue homeostasis.
Specifications
Form
Lyophilized
Additional notes
SDS-PAGE >= 95%
General info
Function
Abundant protease in the cytosolic granules of cytotoxic T-cells and NK-cells which activates caspase-independent pyroptosis when delivered into the target cell through the immunological synapse (PubMed : 1985927, PubMed : 3262682, PubMed : 3263427). It cleaves after Asp (PubMed : 1985927, PubMed : 8258716). Once delivered into the target cell, acts by catalyzing cleavage of gasdermin-E (GSDME), releasing the pore-forming moiety of GSDME, thereby triggering pyroptosis and target cell death (PubMed : 31953257, PubMed : 32188940). Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -9 and -10 (CASP3, CASP9 and CASP10, respectively) to give rise to active enzymes mediating apoptosis (PubMed : 9852092). Cleaves and activates CASP7 in response to bacterial infection, promoting plasma membrane repair (By similarity).
Sequence similarities
Belongs to the peptidase S1 family. Granzyme subfamily.
Subcellular localisation
Cytolytic granule
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com